Pharmacolog launches new software for WasteLog®

Pharmacolog is today launching a brand-new software for WasteLog®. The software is designed to provide a quick and effective solution for controlling the returns of narcotic drugs. WasteLog® includes a number of completely unique features and improved workflow.

The new WasteLog®, which obtains version number 4.6, is tailor-made for quick and effective control of liquid drugs that remains after surgical procedures. Return control, or Waste Screening, is a fundamental component of programs to prevent narcotic drugs from getting in the wrong hands, so called Drug Diversion Prevention Program.

The software has an assisted workflow where each step of the control procedure is clearly indicated to the user with a progress bar. The graphical user interface is optimized for screening pharmaceutical waste with dedicated functionality based on customer experience and feedback. Data security and traceability are ensured through a personal login and storage of all information in a secure cloud service.

Torbjörn Norberg, Product Manager comments: “The introduction of WasteLog 4.6 is a new and unique milestone in Pharmacolog’s work to provide solutions to prevent drug diversion of drugs during medication with injectable narcotics. WasteLog® is the first software specifically adapted to quickly and efficiently verify that the drug to be discarded has not been exchanged or manipulated. With the new software, we also further strengthen our market position in the US market.”

For more information contact:

Mats Högberg, CEO

Phone: +46
70-546 50 21

About Pharmacolog AB

Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through


Send download link

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.